The Belgium Advanced Wound Care Market is expected to grow with a CAGR of 2.0% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below:
Access Full Report at https://www.databridgemarketresearch.com/reports/belgium-advanced-wound-care-market
The Belgium advanced wound care market is a highly consolidated market, including a specific number of key and local players. The market has witnessed increased strategic developments owing to favorable market scenarios.
The major players in the Belgium advanced wound care market are introducing a strong range of product portfolios. This helped companies to maximize sales with an enhanced product portfolio.
For instance,
- In September 2021, 3M signed a patent license agreement with Luxshare Technology Co., Ltd. to use the Twin Axial Cable technology. This will help the company to provide higher-quality, more innovative cable assembly solutions
3M is the dominating player in the Belgium advanced wound care market. Other players in the market are B. Braun Melsungen AG, Coloplast Group, Johnson & Johnson Services, Inc. (Medical Devices Business Services, Inc.) Medtronic, Smith & Nephew, Integra LifeSciences Corporation, Hollister Incorporated, Zimmer Biomet, Organogenesis Inc., ConvaTec Group PLC, Brightwake Ltd, AVERY DENNISON CORPORATION, MIMEDX, Advanced Medical Solutions Group plc, among others.
3M
3M is headquartered in Minnesota, the U.S., founded in 1902. It has public ownership. The company focuses on developing, manufacturing, and distributing a range of products for industrial, safety and graphics, health care, electronics, and energy and consumer use. Industrial, Safety and Graphics, Health Care, Electronics and Energy, and Consumer are the company's business segments, among which Health Care is the market-focused segment.
The company has a wide range of product categories such as Automotive, Commercial Solutions, Design and Construction, Electronics, Energy, Healthcare, Manufacturing, Mining, Oil and Gas, Safety, Transportation. Among these, the market-focused category is Healthcare.
- In October 2019, 3M successfully acquired Acelity, Inc., a provider of wound care and specialty surgical application solutions. With the addition to the product portfolio, the company can provide wound care solutions to its patient. This will help the company to accelerate its position in the wound care market
The company has a presence in the Americas, Europe, the Middle East and Africa, Asia-Pacific. The company has subsidiaries such as 3M Japan Limited (Japan), Meguiar's, Inc (U.S.), 3M India Limited (India), 3M Canada Company – Compagnie 3M Canada (Canada), 3M Thailand Limited (Thailand) among others.
Smith & Nephew
Smith & Nephew is headquartered in Hertfordshire, the U.K, which was established in 1856. It has public ownership. The company is engaged in developing, manufacturing, and marketing novel solutions for Orthopaedics, Advanced Wound Management, Sports Medicine, and ENT. Advanced Wound Management and Reconstruction, Sports Medicine, Trauma & Other Surgical Businesses are the company business segments, among which Advanced Wound Management and Reconstruction are the market-focused segments.
The company offers a wide range of product categories such as Advanced Wound Management, Orthopaedic Reconstruction, Robotics-assistance, Sports Medicine, Trauma and Extremities, Ear, Nose, and Throat. The market-focused category is Advanced Wound Management.
- In April 2019, Smith & Nephew had acquired Osiris Therapeutics, Inc., which offers medical products such as bone graft, skin, and articular cartilage substitutes. It has been completed for USD 19.00 per share in cash, representing a total equity value of around USD 660 million. This acquisition will increase the product portfolio and business of advanced wound management, which will ultimately result in an upsurge in the profit margin of a company
The company has a presence in Africa, Asia, Europe, the Americas, Australasia, and the Middle East. The company has subsidiaries such as ArthroCare (U.S.), Osiris Therapeutics (U.S.), Ceterix Orthopaedics Inc (U.S.), Smith and Nephew, Inc. (U.K.), Blue Belt Technologies Inc (U.S.), among others.
Coloplast Group
Coloplast Group is headquartered in Humlebaek, Denmark, and was found in the year 1954. It has public ownership. The company is engaged in providing products and services related to Ostomy Care, Continence Care, Wound, and Skin Care. Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology are the company business segments, among which Wound and Skin Care is the market-focused segment.
The company offers various product categories such as Ostomy Care, Continence Care, Wound Care, Skin Care, Interventional Urology, Coloplast Care, among which Wound Care is the market-focused category.
- In November 2020, Coloplast Group completed the acquisition of Nine Continents Medical, Inc., an early-stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. This will help the company to enhance its revenue and business function
The company has a presence in North America, Europe, Asia-Pacific, South America, Middle East, and Africa. The company has subsidiaries such as Comfort Medical (U.S.), IncoCare Gunhild Vieler GmbH (Germany), Coloplast Limited (Denmark), SAS LILIAL (France), Coloplast (China) Ltd., among others.
